Explore real-time updates from our clinical pipeline, including ongoing trial progress, patent activity, and emerging commercialization plans across global markets.
April 25, 2024
MangoRx has acquired a global patent portfolio for an oral solution targeting respiratory and oral infections, marking its entry into the non-Rx nutraceutical space with plans for both online and retail distribution.
Read full postJoin us at leading biotech and pharma events where we share insights, present new findings, and engage with the global scientific community.
May 8, 2025
MangoRx has received a Notice of Allowance in Japan for its oral-based respiratory illness prevention technology, reinforcing its global patent portfolio and paving the way for future product expansion in the region.
Read full postOfficial company announcements highlighting research breakthroughs, product launches, and milestone achievements shaping the future of MX-0024.
May 8, 2025
MangoRx has received a Notice of Allowance in Japan for its oral-based respiratory illness prevention technology, reinforcing its global patent portfolio and paving the way for future product expansion in the region.
Read full post
